Stockreport

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and [Read more]